University of Mississippi School of Pharmacy

iForumRx.org

Health EN ↓ 115 episodes

This is the podcast site for iForumRx.org - a community of ambulatory care pharmacy specialists and others interested in the evidence regarding drug therapy and patient management.

Be sure to visit the podcast's website and support the creator: iforumrx.podbean.com

Author

University of Mississippi School of Pharmacy

Category

Health

Podcast website

iforumrx.podbean.com

Latest episode

Nov 6, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Complex Patient Case 3: Treatment Resistant Hypertension 01.12.2023

Reason for Visit: JT was referred by his PCP to the ambulatory care pharmacist for hypertension management. Chief complaint: “My medication is making my mouth dry. I want to stop it.” Guest Authors: Sabrina Silviera, PharmD and Megan Scalia, PharmD, BCACP Expert Panelists: Eric MacLaughlin, PharmD, BCPS and Joseph Saseen, PharmD, BCPS, BCACP, CLS Music by Good Talk

Should We Be Good SPORTs About Supplements for Cholesterol? 17.11.2023

Can supplements marketed for cardiovascular health be used in place of statin therapy? Health professionals have long been wary of nutraceuticals and dietary supplements due to the lack of safety and efficacy regulations. The SPORT trial attempts to provide robust data, to practitioners and patients, on how common supplements perform compared to statin therapy.  Guest Authors: Kaitlyn Phillips, Ph...

Is Telehealth the Hidden (Hyper)Link to Controlling Blood Pressure? 03.11.2023

Do pharmacists providing remote care using telehealth technologies to patients who self-monitor their blood pressure perform as well as physicians and care managers providing care face-to-face? Is BP control better (or worse)? What about patient satisfaction?  The Hyperlink 3 study provides more evidence the telehealth is safe and effective ... and patients prefer it. Guest Authors: Elizabeth Yett...

Personalized Pharmacotherapy for Hypertension: Examining Intra-patient Variability 20.10.2023

Less than 1 in 4 patients with hypertension in the United States have achieved their blood pressure (BP) goal, according to the CDC. Many clinicians only think of changing medications if a patient is having an intolerance to the current regimen. However, individual patients might respond differently to each of the four major anti-hypertensive medication classes and, if we could determine in advanc...

Over-the-Counter Hearing Aids – Where Do They Fit? 06.10.2023

Approximately 1 in 6 adults in the United States report some trouble with their hearing. Despite the prevalence and implications of hearing loss, hearing aid use is strikingly low due to cost and accessibility. In late 2022, the FDA finalized regulations for over-the-counter hearing aids to be sold without medical evaluation or the services of a hearing professional. But will self-fitting OTC hear...

Road to Recovery: Pharmacist-Delivered Comprehensive Medication Management in an SUD Clinic 22.09.2023

More than 46 million people in the US met diagnostic criteria for a substance use disorder (SUD) in 2021. These numbers are staggering and suggest that SUD is more common than diabetes in the United States.  However, only 6% received treatment.  Expanding the care delivery model is essential to improving treatment access and enhancing physical, mental, and social/societal outcomes.  Pharmacists ca...

Gender Affirming Care - Finding the Resources You Need 15.09.2023

Did you know that iForumRx has resource pages related to a wide range of therapeutic areas, patient populations, and practice management issues?  Each resource page provides a succinct annotated list of key clinical trials, clinical practice guidelines, and websites.  A content expert manages each resource page, and the materials are regularly updated to reflect the latest evidence and guidance. ...

Water Wars: Dueling Diuretics - Chlorthalidone vs. Hydrochlorothiazide for Cardiovascular Event Reduction 08.09.2023

Thiazide diuretics are a first-line treatment for patients with high blood pressure (BP), either as monotherapy or, more often, in combination with other first-line agents, but which one should clinicians use? Chlorthalidone was used in several landmark clinical trials and has a favorable pharmacokinetic profile.  But hydrochlorothiazide is the most commonly used (and cheapest) thiazide. Guest Aut...

Beyond Statins: Approaches to Lipid Lowering in 2023 05.09.2023

This episode is a collaboration between the ACCP Ambulatory Care Practice and Research Network (PRN) ... and iForumRx.org. The treatment of dyslipidemia has gotten a lot more complex in recent years as we now have several non-statins that can substantially lower LDL cholesterol and reduce cardiovascular event rates - including PCSK9 monoclonal antibodies, ezetimibe, bempedoic acid, and inclisiran....

Fixed Dose or Treat-to-Target: Does LODESTAR Guide Us on Statin Management? 25.08.2023

There has been a long-standing debate about the optimal approach to statin use, including whether we should initiate therapy using a “fixed-dose”, high-potency statin, or whether we should “start low and go slow” by titrating the dose to a specific LDL-C target. The LODESTAR study was designed to determine if treating LDL-C to a target level produces similar cardiovascular outcomes when compared t...

Making the GRADE: Durability of Glycemic Response in Type 2 Diabetes 11.08.2023

Type 2 diabetes (type 2 DM) is a progressive disease caused by a variety of pathophysiologic defects. However, even with substantial advances in treatment, glycemic control remains elusive, and most patients require combination therapy.  The Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness (GRADE) study sought to investigate the glucose-lowering efficacy of several dia...

Pop Health and Am Care Pharmacy Practice: Achieving Higher Quality, Lower Cost 03.08.2023

This episode is a collaboration between the ACCP Ambulatory Care Practice and Research Network (PRN) ... and iForumRx.org. Population health pharmacists play a critical role in delivering high-quality, cost-effective care to populations at the most risk for adverse outcomes. Panelists:  Ryan Wargo, PharmD, BCACP; Rochelle Rubin, PharmD, BCPS, CDCES; and Shauntá Chamberlin, PharmD, BCPS Produced by...

Top Ten Things Every Clinician Should Know About the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease 28.07.2023

The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines were recently updated with a focus on kidney health in patients with diabetes.  The updated guidelines include recommendations on screening, prevention, and treatment of chronic kidney disease (CKD), including the use of SGLT2 inhibitors, finerenone, and ACE inhibitors or ARBs.  The written commentary posted on the iForumRx website p...

Is In-Personal Care Better than Care Delivered at a Distance? 14.07.2023

If we’ve learned anything from the COVID-19 pandemic, it’s that delivering healthcare to patients at a distance is possible. Telehealth can help increase access to care for patients in medically underserved communities and for those who have transportation, cost, and time barriers.  But one question has not been adequately answered—is telehealth an effective method to deliver primary care?    Gues...

How Many Patients Can a Pharmacist Reasonably Manage? Estimating An Appropriate Panel Size 23.06.2023

Several studies have shown the benefits of involving pharmacists in the primary care setting.  And there are some recommendations regarding an appropriate physician-patient panel size per pharmacist.  But what's the ideal ambulatory care pharmacist-patient panel size? Guest Authors: Benjamin King, PharmD, BCACP, Jubilee Winar, PharmD, and Jasmin Ortiz, PharmD Music by Good Talk

Is There a CLEAR Role for Bempedoic Acid in Cardiovascular Risk Reduction? 09.06.2023

There are a variety of non-statin lipid-lowering medications with proven cardiovascular benefits; however, most of the evidence supporting their use has been as an adjunct with a statin. Bempedoic acid offers a novel mechanism of action to treat hypercholesterolemia. But is there a CLEAR role for bempedoic acid in the treatment and prevention of ASCVD in statin-intolerant patients? Guest Authors:...

Is MBSR* as Good as Meds for Anxiety Disorders? 26.05.2023

One in five people in the U.S. report suffering from anxiety in the past year, and one in three will experience an anxiety disorder in their lifetime, but 40% of patients go untreated. Perhaps patients are disinterested (or distrust) in traditional pharmacotherapy ... or perhaps it is due to a lack of availability of services (like cognitive behavioral therapy – CBT). Many patients (and clinicians...

GLP-1 Receptor Agonists and SGLT2 Inhibitors: Don’t Sugarcoat the Costs! 12.05.2023

The cost of diabetes in the United States has nearly doubled over the past decade in part due to rising prices and the cost of newer medications used to manage the disease.  With new, improved, but costly alternatives available, it’s going to be challenging for ambulatory care practitioners to evaluate if the potential benefits of using these newer medication classes as first-line therapy (instead...

Is Combination Therapy Superior to Monotherapy for Painful Diabetic Peripheral Neuropathy? 28.04.2023

Several medication classes can be used to treat diabetic peripheral neuropathic pain (DPNP); however, many patients have a suboptimal response or experience dose-limiting side effects. Treatment guidelines suggest several first-line options but, in the absence of compelling evidence, offer no direction as to which agent to try first or if we should consider combination therapy. Guest Authors: Shil...

How VITAL is Vitamin D in Preventing Statin Associated Muscle Symptoms (SAMS)? 14.04.2023

You’ve probably encountered many patients who have experienced muscle symptoms after starting a statin.  Statin-associated muscle symptoms (SAMS) contribute to treatment discontinuation and significantly increase cardiovascular (CV) adverse events and mortality. What strategies do you recommend to increase statin tolerance?  Guest Author:  Rick Hess, PharmD, CDCES, BCACP Music by Good Talk

Under Pressure: Measuring and Managing Hypertension 07.04.2023

This episode is a collaboration between the ACCP Ambulatory Care Practice and Research Network (PRN) ... and iForumRx.org. Measuring blood pressure (BP) and managing hypertension are among the essential roles that pharmacists play in ambulatory care and community-based practice environments.  This program is a question-and-answer session as a follow-up to the Ambulatory Care PRN program at the 202...

Top Ten Things Every Clinician Should Know About Payment for Pharmacists’ Patient Care Services 23.03.2023

Patient for pharmacists' patient care services remains a challenge.  While provider status at the federal level has not yet been realized, there has been a steady growth of payers and programs covering services provided by pharmacists in recent years. Guest Author: E. Michael Murphy, PharmD, MBA Music by Good Talk

Complex Patient Case 2 - Managing Adverse Effects 17.03.2023

Reason for Visit: The patient is here today for hypotension and diabetes follow-up. The primary care physician has consulted the clinical pharmacist regarding hypotension. Chief Complaint: “I feel dizzy when I stand up and feel like my heart is racing. I have never passed out, but it feels like I might, and I usually have to sit back down." Guest Authors:  Kellie Ball, PharmD and Johnathon Proctor...

Preventing Autoimmune Disease: Can Supplements Get the Job Done? 03.03.2023

Currently, there are no known safe, effective, and inexpensive ways that can prevent or reduce the risk of developing autoimmune diseases. Any strategy that could reduce the chances of developing an autoimmune disorder would be welcomed by practitioners and patients alike.  Perhaps vitamin D and omega 3 fatty acid supplementation can get the job done. Guest Authors: Rileigh Provenza, PharmD and Ni...

Top Ten Things Every Clinician Should Know About Treating Obesity 18.02.2023

Obesity is a chronic, progressive, multi-factorial, neurobehavioral disease characterized by excessive adipose tissue.  Here are some things every clinician should know about treating overweight and obesity but be sure to read the written commentary posted on iForumRx.org Guest Authors:  Jennifer N. Clements, PharmD, BCPS, BCACP, CDCES, BC-ADM and Seena L. Haines, PharmD., BCACP, NBC-HWC, CHWC Mus...

Listen to the iForumRx.org podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.